Journal article
DNA methylation signatures associated with cardiometabolic risk factors in children from India and The Gambia: results from the EMPHASIS study
- Abstract:
- BACKGROUND: The prevalence of cardiometabolic disease (CMD) is rising globally, with environmentally induced epigenetic changes suggested to play a role. Few studies have investigated epigenetic associations with CMD risk factors in children from low- and middle-income countries. We sought to identify associations between DNA methylation (DNAm) and CMD risk factors in children from India and The Gambia. RESULTS: Using the Illumina Infinium HumanMethylation 850 K Beadchip array, we interrogated DNAm in 293 Gambian (7-9 years) and 698 Indian (5-7 years) children. We identified differentially methylated CpGs (dmCpGs) associated with systolic blood pressure, fasting insulin, triglycerides and LDL-Cholesterol in the Gambian children; and with insulin sensitivity, insulinogenic index and HDL-Cholesterol in the Indian children. There was no overlap of the dmCpGs between the cohorts. Meta-analysis identified dmCpGs associated with insulin secretion and pulse pressure that were different from cohort-specific dmCpGs. Several differentially methylated regions were associated with diastolic blood pressure, insulin sensitivity and fasting glucose, but these did not overlap with the dmCpGs. We identified significant cis-methQTLs at three LDL-Cholesterol-associated dmCpGs in Gambians; however, methylation did not mediate genotype effects on the CMD outcomes. CONCLUSION: This study identified cardiometabolic biomarkers associated with differential DNAm in Indian and Gambian children. Most associations were cohort specific, potentially reflecting environmental and ethnic differences
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.7MB, Terms of use)
-
- Publisher copy:
- 10.1186/s13148-021-01213-3
Authors
+ The Wellcome Trust DBT India Alliance
More from this funder
- Funder identifier:
- 10.13039/501100009053
- Grant:
- BT/IN/DBT-MRC/DFID/24/GRC/2015-16
+ Medical Research Council
More from this funder
- Funder identifier:
- 10.13039/501100000265
- Grant:
- mc-a760-5qx00
- MR/M0051186/1
- u105960371
- U105960371
- u123261351
- mr/m01424x/1
- u1232661351
- Publisher:
- BioMed Central
- Journal:
- Clinical Epigenetics More from this journal
- Volume:
- 14
- Issue:
- 1
- Pages:
- 6-6
- Article number:
- 6
- Publication date:
- 2022-01-09
- DOI:
- EISSN:
-
1868-7083
- ISSN:
-
1868-7075
- Language:
-
English
- Keywords:
- Pubs id:
-
1494722
- Local pid:
-
pubs:1494722
- Source identifiers:
-
W4206266040
- Deposit date:
-
2026-05-11
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record